Nanjing Xingyin Pharmaceutical Research Co., Ltd. was established in 2000, focusing on clinical new drug research and development. Since the establishment of the company, its self-developed drugs include zinc gluconate nasal spray (Xingrelin), triamcinolone acetonide nasal spray (Xingrec), Gegen decoction mixture, compound codeine phosphate oral solution, Zalaiplon tablets, etc. These drugs are widely used in clinical practice, and their exact efficacy is highly respected by doctors and patients. At the same time, the company actively declared patented technology, has applied for 17 patents such as Gegen Tang mixture manufacturing process, and obtained 6 authorized patents.
In recent years, Nanjing Xingyin Drug Research Co., Ltd. involved in the development of clinical new drugs, including antihypertensive drugs, hypoglycemic drugs, immune system drugs, ophthalmic drugs, antidepressants, cardiovascular drugs, etc. These products will gradually enter the clinical approval or production procedures, will soon be promoted to the market, so that the majority of clinicians and patients benefit.
